Michael A. Panzara - Mar 18, 2022 Form 3 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
Glenna Mileson, Attorney-in-fact for Michael Panzara
Stock symbol
ATHA
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
3
Date filed
3/21/2022, 04:36 PM
Previous filing
Feb 18, 2022
Next filing
May 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATHA No securities are beneficially owned. 0 Mar 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATHA No securities are beneficially owned. Mar 18, 2022 Not Applicable 0 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.